Iovance Biotherapeutics Inc (IOVA)

10.89
0.10 0.91
NASDAQ
Prev Close 10.99
Open 11.01
Day Low/High 10.71 / 11.19
52 Wk Low/High 7.26 / 19.90
Volume 769.90K
Exchange NASDAQ
Shares Outstanding 123.51B
Market Cap 1.36B
Div & Yield N.A. (N.A)

Latest News

A Lesson to Learn From Thursday's Market Action

A Lesson to Learn From Thursday's Market Action

You don't have to be Sigmund Freud to understand the psychology here.

Small-Cap Stocks Lead the Way

Small-Cap Stocks Lead the Way

As interest rate fears ease slightly, indexes rebound.

4 Small Speculative Names on My Radar

4 Small Speculative Names on My Radar

While I'm waiting for some index excitement I'm focused on trades in individual stocks.

Lennar Is One of 6 Stocks Poised to Change Direction

Lennar Is One of 6 Stocks Poised to Change Direction

These names are showing technical characteristics of either bullish or bearish reversal patterns over the past week.

Sound Familiar? Dovish Fed Talk Induces Stock Reversal

Sound Familiar? Dovish Fed Talk Induces Stock Reversal

The market's reaction to James Bullard's comments this morning is following an all-too-common pattern.

Biotech Heats Up as Fear of Missing Out Returns

Biotech Heats Up as Fear of Missing Out Returns

It's hard to believe the bounce will continue to run in V-shaped fashion.

Focused on Two Sectors

Focused on Two Sectors

If we have a little consolidating action here the buyers will start pushing again.

Markets Face Heavy News Flow in Next 48 Hours

Markets Face Heavy News Flow in Next 48 Hours

In addition to the State of the Union address and the Fed interest rate decision, companies representing about 25% of the Nasdaq 100's market cap will report results in the next two days.

'Normal' Market Selloff Feels Much Worse Than It Really Is

'Normal' Market Selloff Feels Much Worse Than It Really Is

While painful to longs, the market will be better for it.

This Market Badly Needs a Rest

This Market Badly Needs a Rest

It would be a longer-term positive if the overbought conditions are alleviated.

Building in Biotech, Adding to Twitter

Building in Biotech, Adding to Twitter

The challenge of this market is to keep finding new buy entries as more and more stocks become extended.

Market Gets a Little Bumpy, but Stock-Picking Still Rocks

Market Gets a Little Bumpy, but Stock-Picking Still Rocks

Only when the picking worsens will I start to worry.

Biotech Looks Good and I'm Buying

Biotech Looks Good and I'm Buying

The sector has been a great trading group lately and I bought these 2 names this morning.

In This Booming Stock Market, Think Like a Programmer Not a Critic

In This Booming Stock Market, Think Like a Programmer Not a Critic

What drives the trading action are structural issues, not macroeconomic news events or political drama.

The Stock Market Is Facing One Big Obstacle Right Now

The Stock Market Is Facing One Big Obstacle Right Now

You have to wonder how much longer we can run without a pullback of at least 2%.